Nonfasting glucose, ischemic heart disease, and myocardial infarction: A mendelian randomization study

Journal of the American College of Cardiology

Volumn 59, Issue 25, 2012, Pages 2356-2365

  Benn, Marianne ^a,b   Tybjærg Hansen, Anne ^a,b,c,d   McCarthy, Mark I ^e,f,g   Jensen, Gorm B ^b,c   Grande, Peer ^b,c   Nordestgaard, Borge G ^a,b,d  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b Mental Health Services CPH   (Denmark)

^c Rigshospitalet   (Denmark)

^d BISPEBJERG HOSPITAL   (Denmark)

^e UNIVERSITY OF OXFORD   (United Kingdom)

^f UNIVERSITY OF OXFORD   (United Kingdom)

^g CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

cardiovascular disease; diabetes mellitus; epidemiology; nonfasting; plasma glucose; post prandial

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADCY5 GENE; ADRA2A GENE; ADULT; AGE; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BODY MASS; CONTROLLED STUDY; DGKB GENE; DIABETES MELLITUS; DISEASE ASSOCIATION; EXERCISE ELECTROCARDIOGRAPHY; FEMALE; G6PC2 GENE; GCK GENE; GENDER; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; GLUCOSE BLOOD LEVEL; HEART INFARCTION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PRIORITY JOURNAL; RISK ASSESSMENT; SEX DIFFERENCE;

ADULT; AGED; ALLELES; BLOOD GLUCOSE; BODY MASS INDEX; CHOLESTEROL, HDL; DENMARK; FEMALE; GENOTYPE; HUMANS; HYPERTENSION; KAPLAN-MEIER ESTIMATE; MALE; MENDELIAN RANDOMIZATION ANALYSIS; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; ODDS RATIO; POLYMORPHISM, GENETIC; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS;

EID: 84862205208     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2012.02.043     Document Type: Article

References (35)

1. N. Sarwar, P. Gao, S.R. Seshasai Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies Lancet 375 2010 2215 2222
2. M. Coutinho, H.C. Gerstein, Y. Wang, S. Yusuf The relationship between glucose and incident cardiovascular events A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years Diabetes Care 22 1999 233 240 (Pubitemid 29056916)
3. K.K. Ray, S.R. Seshasai, S. Wijesuriya Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials Lancet 373 2009 1765 1772
4. D.A. Lawlor, R.M. Harbord, J.A. Sterne, N. Timpson, S.G. Davey Mendelian randomization: using genes as instruments for making causal inferences in epidemiology Stat Med 27 2008 1133 1163 (Pubitemid 351395448)
5. I. Prokopenko, C. Langenberg, J.C. Florez Variants in MTNR1B influence fasting glucose levels Nat Genet 41 2009 77 81
6. C. Sabatti, S.K. Service, A.L. Hartikainen Genome-wide association analysis of metabolic traits in a birth cohort from a founder population Nat Genet 41 2009 35 46
7. J.C. Chambers, W. Zhang, D. Zabaneh Common genetic variation near melatonin receptor MTNR1B contributes to raised plasma glucose and increased risk of type 2 diabetes among Indian Asians and European Caucasians Diabetes 58 2009 2703 2708
8. J. Dupuis, C. Langenberg, I. Prokopenko New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk Nat Genet 42 2010 105 116
9. B.F. Voight, L.J. Scott, V. Steinthorsdottir Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis Nat Genet 42 2010 579 589
10. S. Okumura, J. Kawabe, A. Yatani Type 5 adenylyl cyclase disruption alters not only sympathetic but also parasympathetic and calcium-mediated cardiac regulation Circ Res 93 2003 364 371 (Pubitemid 37048249)
11. A.J. Risselada, J. Vehof, R. Bruggeman Association between the 1291-C/G polymorphism in the adrenergic alpha-2a receptor and the metabolic syndrome J Clin Psychopharmacol 30 2010 667 671
12. B.G. Nordestgaard, M. Benn, P. Schnohr, A. Tybjaerg-Hansen Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women JAMA 298 2007 299 308 (Pubitemid 47080484)
13. J. Zacho, A. Tybjaerg-Hansen, J.S. Jensen, P. Grande, H. Sillesen, B.G. Nordestgaard Genetically elevated C-reactive protein and ischemic vascular disease N Engl J Med 359 2008 1897 1908
14. R. Frikke-Schmidt, B.G. Nordestgaard, M.C. Stene Association of loss-of-function mutations in the ABCA1 gene with high-density lipoprotein cholesterol levels and risk of ischemic heart disease JAMA 299 2008 2524 2532 (Pubitemid 351787208)
15. M. Benn, B.G. Nordestgaard, P. Grande, P. Schnohr, A. Tybjaerg-Hansen PCSK9 R46L, low-density lipoprotein cholesterol levels, and risk of ischemic heart disease: 3 independent studies and meta-analyses J Am Coll Cardiol 55 2010 2833 2842
16. K. Thygesen, J.S. Alpert, H.D. White Universal definition of myocardial infarction J Am Coll Cardiol 50 2007 2173 2195 (Pubitemid 350123680)
17. K.G. Alberti, R.H. Eckel, S.M. Grundy Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity Circulation 120 2009 1640 1645
18. R. Clarke, M. Shipley, S. Lewington Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies Am J Epidemiol 150 1999 341 353 (Pubitemid 29383482)
19. D.S. Falconer, T.F.S. Mackay Introduction to Quantitative Genetics 4th ed. 1996 Addison-Wesley Longman Harlow, Essex, UK
20. D.G. Altman, J.M. Bland Interaction revisited: the difference between two estimates BMJ 326 2003 219 (Pubitemid 36143396)
21. B. Pierce, H. Ahsan, T. VanderWeele Power and instrument strength requirements for Mendelian randomization studies using multiple genetic variants Int J Epidemiol 40 2010 740 752
22. B.G. Nordestgaard Does elevated C-reactive protein cause human atherothrombosis? Novel insights from genetics, intervention trials, and elsewhere Curr Opin Lipidol 20 2009 393 401
23. B.G. Nordestgaard, M.J. Chapman, K. Ray Lipoprotein (a) as a cardiovascular risk factor: current status Eur Heart J 31 2010 2844 2853
24. M. Brownlee, R.G. Spiro Biochemistry of the basement membrane in diabetes mellitus Adv Exp Med Biol 124 1979 141 156
25. D.A. Greene, J.C. Arezzo, M.B. Brown Effect of aldose reductase inhibition on nerve conduction and morphometry in diabetic neuropathy Zenarestat Study Group Neurology 53 1999 580 591 (Pubitemid 29382055)
26. R. Rucinsky, A. Cook, S. Haley, R. Nelson, D.L. Zoran, M. Poundstone AAHA diabetes management guidelines for dogs and cats J Am Anim Hosp Assoc 46 2010 215 224
27. UK Prospective Diabetes Study (UKPDS) Group Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) Lancet 352 1998 854 865
28. H.C. Gerstein, M.E. Miller, R.P. Byington Effects of intensive glucose lowering in type 2 diabetes N Engl J Med 358 2008 2545 2559 (Pubitemid 351831356)
29. J.A. Dormandy, B. Charbonnel, D.J. Eckland Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial in macroVascular Events): a randomised controlled trial Lancet 366 2005 1279 1289 (Pubitemid 41416583)
30. R. Wilcox, S. Kupfer, E. Erdmann Effects of pioglitazone on major adverse cardiovascular events in high-risk patients with type 2 diabetes: results from PROspective pioglitAzone Clinical Trial in macroVascular Events (PROactive 10) Am Heart J 155 2008 712 717
31. A. Patel, S. MacMahon, J. Chalmers Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes N Engl J Med 358 2008 2560 2572 (Pubitemid 351831357)
32. W. Duckworth, C. Abraira, T. Moritz Glucose control and vascular complications in veterans with type 2 diabetes N Engl J Med 360 2009 129 139
33. L.J. Rasmussen-Torvik, M. Li, W. Kao Association of a fasting glucose genetic risk score with subclinical atherosclerosis: the Atherosclerosis Risk In Communities (ARIC) study Diabetes 9 2011 295 298
34. M. Hanefeld, S. Fischer, U. Julius Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up Diabetologia 39 1996 1577 1583 (Pubitemid 26397370)
35. S.M. Haffner The importance of hyperglycemia in the nonfasting state to the development of cardiovascular disease Endocr Rev 19 1998 583 592 (Pubitemid 28467712)